Real-time enrollment status for this asthma clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 2:28 AM UTC
| NCT Number | NCT07782996 |
| Recruiting Status | Recruiting |
| Condition | Asthma |
| Phase | PHASE3 |
| Target Enrollment | 370 participants |
| Active Locations | 1 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | September 30, 2026 (2 weeks ago) |
As of October 15, 2026: Clinical trial NCT07782996 is currently recruiting participants. This phase3 study for asthma is actively seeking new participants at 1 location across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07782996 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07782996 was last updated 2 weeks ago (September 30, 2026). HelloStudys verifies this status automatically.